158 related articles for article (PubMed ID: 33958567)
1. Multimodal Evoked Potentials as Candidate Prognostic and Response Biomarkers in Clinical Trials of Multiple Sclerosis.
Hardmeier M; Fuhr P
J Clin Neurophysiol; 2021 May; 38(3):171-180. PubMed ID: 33958567
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of multimodal evoked potentials in multiple sclerosis: the EP score.
Invernizzi P; Bertolasi L; Bianchi MR; Turatti M; Gajofatto A; Benedetti MD
J Neurol; 2011 Nov; 258(11):1933-9. PubMed ID: 21479648
[TBL] [Abstract][Full Text] [Related]
3. A new role for evoked potentials in MS? Repurposing evoked potentials as biomarkers for clinical trials in MS.
Hardmeier M; Leocani L; Fuhr P
Mult Scler; 2017 Sep; 23(10):1309-1319. PubMed ID: 28480798
[TBL] [Abstract][Full Text] [Related]
4. Prognostic biomarkers in primary progressive multiple sclerosis: Validating and scrutinizing multimodal evoked potentials.
Hardmeier M; Schlaeger R; Lascano AM; Toffolet L; Schindler C; Gobbi C; Lalive P; Kuhle J; Kappos L; Fuhr P
Clin Neurophysiol; 2022 May; 137():152-158. PubMed ID: 35316624
[TBL] [Abstract][Full Text] [Related]
5. The utility of multimodal evoked potentials in multiple sclerosis prognostication.
Ramanathan S; Lenton K; Burke T; Gomes L; Storchenegger K; Yiannikas C; Vucic S
J Clin Neurosci; 2013 Nov; 20(11):1576-81. PubMed ID: 23827173
[TBL] [Abstract][Full Text] [Related]
6. Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis.
Giffroy X; Maes N; Albert A; Maquet P; Crielaard JM; Dive D
BMC Neurol; 2016 Jun; 16():83. PubMed ID: 27245221
[TBL] [Abstract][Full Text] [Related]
7. The Use of Motor-Evoked Potentials in Clinical Trials in Multiple Sclerosis.
Fernández V
J Clin Neurophysiol; 2021 May; 38(3):166-170. PubMed ID: 33958566
[TBL] [Abstract][Full Text] [Related]
8. Do evoked potentials contribute to the functional follow-up and clinical prognosis of multiple sclerosis?
Giffroy X; Maes N; Albert A; Maquet P; Crielaard JM; Dive D
Acta Neurol Belg; 2017 Mar; 117(1):53-59. PubMed ID: 27194163
[TBL] [Abstract][Full Text] [Related]
9. Evoked potentials in clinical trials for multiple sclerosis.
Emerson RG
J Clin Neurophysiol; 1998 Mar; 15(2):109-16. PubMed ID: 9563577
[TBL] [Abstract][Full Text] [Related]
10. Evoked potentials to test a treatment of chronic multiple sclerosis.
Anderson DC; Slater GE; Sherman R; Ettinger MG
Arch Neurol; 1987 Dec; 44(12):1232-6. PubMed ID: 3675257
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers and Surrogate End points in Multiple Sclerosis Trials: Regulatory Issues.
Skeen MB; Pani L
J Clin Neurophysiol; 2021 May; 38(3):181-185. PubMed ID: 33958568
[TBL] [Abstract][Full Text] [Related]
12. Monitoring multiple sclerosis by multimodal evoked potentials: Numerically versus ordinally scaled scoring systems.
Schlaeger R; Hardmeier M; D'Souza M; Grize L; Schindler C; Kappos L; Fuhr P
Clin Neurophysiol; 2016 Mar; 127(3):1864-71. PubMed ID: 26754876
[TBL] [Abstract][Full Text] [Related]
13. Latency of Multifocal Visual Evoked Potential in Multiple Sclerosis: A Visual Pathway Biomarker for Clinical Trials of Remyelinating Therapies.
Klistorner A; Triplett JD; Barnett MH; Yiannikas C; Barton J; Parratt J; You Y; Graham SL
J Clin Neurophysiol; 2021 May; 38(3):186-191. PubMed ID: 33235179
[TBL] [Abstract][Full Text] [Related]
14. Motor evoked potentials and disability in secondary progressive multiple sclerosis.
Facchetti D; Mai R; Micheli A; Marcianó N; Capra R; Gasparotti R; Poloni M
Can J Neurol Sci; 1997 Nov; 24(4):332-7. PubMed ID: 9398981
[TBL] [Abstract][Full Text] [Related]
15. Evoked potentials in monitoring multiple sclerosis.
Leocani L; Medaglini S; Comi G
Neurol Sci; 2000; 21(4 Suppl 2):S889-91. PubMed ID: 11205369
[TBL] [Abstract][Full Text] [Related]
16. Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis.
Kallmann BA; Fackelmann S; Toyka KV; Rieckmann P; Reiners K
Mult Scler; 2006 Feb; 12(1):58-65. PubMed ID: 16459720
[TBL] [Abstract][Full Text] [Related]
17. Use of evoked potentials in the diagnosis and follow-up of multiple sclerosis.
Drislane FW
Clin Neurosci; 1994; 2(3-4):196-201. PubMed ID: 7749888
[TBL] [Abstract][Full Text] [Related]
18. Delayed visual perception and delayed visual evoked potentials in the spinal form of multiple sclerosis and in retrobulbar neuritis.
Regan D; Milner BA; Heron JR
Brain; 1976 Mar; 99(1):43-66. PubMed ID: 963530
[TBL] [Abstract][Full Text] [Related]
19. Evoked potentials in multiple sclerosis.
Kraft GH
Phys Med Rehabil Clin N Am; 2013 Nov; 24(4):717-20. PubMed ID: 24314688
[TBL] [Abstract][Full Text] [Related]
20. Early disturbances in multimodal evoked potentials as a prognostic factor for long-term disability in relapsing-remitting multiple sclerosis patients.
London F; El Sankari S; van Pesch V
Clin Neurophysiol; 2017 Apr; 128(4):561-569. PubMed ID: 28231474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
